Fosrenol will be a new phosphate binder for dialysis patients

Fosrenol will be a new phosphate binder for dialysis patients.

It's an alternative to PhosLo, Renagel, AlternaGel, etc.

Phosphate increases in the blood as kidney function declines. This leads to hypocalcemia and secondary hyperparathyroidism.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote